Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11207662rdf:typepubmed:Citationlld:pubmed
pubmed-article:11207662lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0040421lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0017661lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0007584lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:11207662lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:11207662pubmed:issue2lld:pubmed
pubmed-article:11207662pubmed:dateCreated2001-3-14lld:pubmed
pubmed-article:11207662pubmed:abstractTextIgAN is a common form of primary glomerulonephritis and also a disease of tonsillar focal infection. The comprehensive mechanism underlying this disease remains to be defined. To better understand its pathogenesis, we investigated tonsillar CD5+ B cells (B-1 cells) with respect to IgA synthesis. Germinal centre (GC) B cells were isolated from the tonsils of IgAN patients and the number of B-1 cells in the GC determined by flow cytometry. GC B-1 and B-2 (CD5- B) cells were purified by cell sorter, the cells were incubated with agonist anti-CD40 MoAb and the ability for antibody production by B-1 and B-2 cells determined by ELISPOT assay. GC B-1 cells and B-2 cells were incubated with agonist anti-Fas MoAb, and apoptosis in GC B-1 cells and B-2 cells was analysed by flow cytometry. Although B-1 cells do not usually take part in the GC reaction, an increase in B-1 cell numbers was observed in the GC of tonsils from IgAN patients. These B-1 cells were likely IgA1 antibody-producing cells, since the prominent IgA subclass in IgAN is generally considered to be IgA1. Although Fas-dependent apoptosis is essential for the elimination of activated B cells, these B-1 cells showed a reduced susceptibility to Fas-mediated apoptosis. It is conceivable that activated B-1 cells may survive in the GC due to impaired apoptosis and thus produce abnormal antibodies. These findings suggest that the immune responses of B-1 cells in the tonsillar GC could thus have an impact on the pathogenesis of IgAN.lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:languageenglld:pubmed
pubmed-article:11207662pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:citationSubsetIMlld:pubmed
pubmed-article:11207662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11207662pubmed:statusMEDLINElld:pubmed
pubmed-article:11207662pubmed:monthFeblld:pubmed
pubmed-article:11207662pubmed:issn0009-9104lld:pubmed
pubmed-article:11207662pubmed:authorpubmed-author:SuzukiMMlld:pubmed
pubmed-article:11207662pubmed:authorpubmed-author:AritaMMlld:pubmed
pubmed-article:11207662pubmed:authorpubmed-author:MogiGGlld:pubmed
pubmed-article:11207662pubmed:authorpubmed-author:KodamaSSlld:pubmed
pubmed-article:11207662pubmed:issnTypePrintlld:pubmed
pubmed-article:11207662pubmed:volume123lld:pubmed
pubmed-article:11207662pubmed:ownerNLMlld:pubmed
pubmed-article:11207662pubmed:authorsCompleteYlld:pubmed
pubmed-article:11207662pubmed:pagination301-8lld:pubmed
pubmed-article:11207662pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:meshHeadingpubmed-meshheading:11207662...lld:pubmed
pubmed-article:11207662pubmed:year2001lld:pubmed
pubmed-article:11207662pubmed:articleTitleIncrease in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis.lld:pubmed
pubmed-article:11207662pubmed:affiliationDepartment of Otolaryngology, Oita Medical University, Hazama-machi, Oita, Japan.lld:pubmed
pubmed-article:11207662pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11207662pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11207662lld:pubmed